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The risk of overtreatment in localized prostate cancer has become a subject of paramount importance and is one of the major reasons behind some of the negative perceptions of screening. Although treatment today has less morbidity than in the past, there is still significant risk associated with all available treatment options. To dissociate screening from treatment, the concepts of watchful waiting (WW) and active surveillance (AS) have gained widespread attention and appeal.
The concept of WW implies that patients are followed up without intervention until symptoms manifest or clinical or metastatic progression becomes apparent. The concept of WW has become less attractive, especially for younger patients, given that a large randomized clinical trial demonstrated that radical prostatectomy significantly improved metastasisfree and overall survival compared with WW. 1 A compromise between WW and immediate intervention has given rise to the concept of AS. Given the low risk of 10-year cancer-specific mortality, AS has become a recommended option for selected patients diagnosed with apparently low-risk cancer. 2, 3 Low-risk disease is generally defined as Gleason grade 6 cancers with prostate-specific antigen (PSA) findings below 10 ng/mL and nothing more than clinical T2a disease on digital rectal examination (DRE). The subclassification of very-low-risk cancer is defined as 2 or fewer positive biopsy findings with less than 50% of any core being cancerous. 2 These cases are often considered optimal for AS. Patients under AS are followed up regularly with PSA measurements and DREs and usually rebiopsied at variable time points. The plan is to intervene if and when progression to a more aggressive phenotype occurs.
3,4
Whether we can safely expand the concept of AS to some patients with intermediate-risk prostate cancers has become a subject of interest to both physicians and patients. 
